TrialBone marrow transplantation2019

The new refined minnesota risk score for acute graft-versus-host disease predicts overall survival and non-relapse mortality after T cell-replete haploidentical stem cell transplant with post-transplant cyclophosphamide.

Jacopo Mariotti et al.PubMed ↗Publisher ↗

No numbers read from the abstract.